Bioscience leaders outlined the challenges of bringing their discoveries to market and growing in New Haven as part of a panel discussion with public officials on Friday at the College Street headquarters of Alexion AstraZeneca Rare Disease.
The livestreamed meeting was prompted by the visit of National Science Foundation Director Sethuraman Panchanathan, an enthusiastic booster of Connecticut’s public-private partnerships in bioscience innovation.